Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Carnitine treatment improved quality-of-life measure in a sample of Midwestern hemodialysis patients.

Steiber AL, Davis AT, Spry L, Strong J, Buss ML, Ratkiewicz MM, Weatherspoon LJ.

JPEN J Parenter Enteral Nutr. 2006 Jan-Feb;30(1):10-5.

PMID:
16387893
2.
3.

[Combined therapy with L-carnitine and erythropoietin of anemia in chronic kidney failure patients undergoing hemodialysis].

Wanic-Kossowska M, Kazmierski M, Pawliczak E, Kobelski M.

Pol Arch Med Wewn. 2007 Jan-Feb;117(1-2):14-9. Polish.

4.

Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial.

Higuchi T, Abe M, Yamazaki T, Okawa E, Ando H, Hotta S, Oikawa O, Kikuchi F, Okada K, Soma M.

Am J Kidney Dis. 2016 Feb;67(2):260-70. doi: 10.1053/j.ajkd.2015.09.010. Epub 2015 Oct 23.

PMID:
26508680
5.

Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects.

Golper TA, Wolfson M, Ahmad S, Hirschberg R, Kurtin P, Katz LA, Nicora R, Ashbrook D, Kopple JD.

Kidney Int. 1990 Nov;38(5):904-11.

6.

L-carnitine treatment in incident hemodialysis patients: the multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trial.

Mercadal L, Coudert M, Vassault A, Pieroni L, Debure A, Ouziala M, Depreneuf H, Fumeron C, Servais A, Bassilios N, Bécart J, Assogba U, Allouache M, Bouali B, Luong N, Dousseaux MP, Tezenas-du Montcel S, Deray G.

Clin J Am Soc Nephrol. 2012 Nov;7(11):1836-42. doi: 10.2215/CJN.12431211. Epub 2012 Aug 30.

7.

Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.

Semeniuk J, Shalansky KF, Taylor N, Jastrzebski J, Cameron EC.

Clin Nephrol. 2000 Dec;54(6):470-7.

PMID:
11140808
9.

Altered carnitine metabolism in dialysis patients with reduced physical function may be due to dysfunctional fatty acid oxidation.

Murphy WJ, Steiber A, Connery GC, Carder J, Spry L, Hoppel C.

Nephrol Dial Transplant. 2012 Jan;27(1):304-10. doi: 10.1093/ndt/gfr334. Epub 2011 Sep 12.

PMID:
21765185
11.
12.

Reduced requirement for erythropoietin with quotidian hemodialysis therapy.

Klarenbach S, Heidenheim AP, Leitch R, Lindsay RM; Daily/Nocturnal Dialysis Study Group..

ASAIO J. 2002 Jan-Feb;48(1):57-61.

PMID:
11814098
13.

Quality of life during and between hemodialysis treatments: role of L-carnitine supplementation.

Sloan RS, Kastan B, Rice SI, Sallee CW, Yuenger NJ, Smith B, Ward RA, Brier ME, Golper TA.

Am J Kidney Dis. 1998 Aug;32(2):265-72.

PMID:
9708611
14.

Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects.

Ahmad S, Robertson HT, Golper TA, Wolfson M, Kurtin P, Katz LA, Hirschberg R, Nicora R, Ashbrook DW, Kopple JD.

Kidney Int. 1990 Nov;38(5):912-8.

15.

Anemia and carnitine supplementation in hemodialyzed patients.

Kletzmayr J, Mayer G, Legenstein E, Heinz-Peer G, Leitha T, Hörl WH, Kovarik J.

Kidney Int Suppl. 1999 Mar;69:S93-106.

PMID:
10084293
16.

Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review.

Hurot JM, Cucherat M, Haugh M, Fouque D.

J Am Soc Nephrol. 2002 Mar;13(3):708-14. Review.

17.

Do diabetic dialysis patients require more or less of erythropoietin?

Mitwalli A, Alsuwaida A, Wakeel JA, Usama S, Zainalddain N, Al Ghonaim M, Hammad D.

Ann Saudi Med. 2013 Sep-Oct;33(5):457-63. doi: 10.5144/0256-4947.2013.457.

18.

Effect of L-carnitine supplementation in hemodialysis patients.

Veselá E, Racek J, Trefil L, Jankovy'ch V, Pojer M.

Nephron. 2001 Jul;88(3):218-23.

PMID:
11423752
19.

Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis.

Lilien MR, Duran M, Quak JM, Frankhuisen JJ, Schröder CH.

Pediatr Nephrol. 2000 Nov;15(1-2):17-20.

PMID:
11095004
20.

Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients.

Keven K, Kutlay S, Nergizoglu G, Ertürk S.

Am J Kidney Dis. 2003 Jun;41(6):1233-9.

PMID:
12776276

Supplemental Content

Support Center